Sculptor Capital’s CalciMedica CALC Stock Holding History

Sculptor Capital’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,350	Closed	-$240K	–	1231
2021 Q4	$240K	Hold	9,350	–	–	﹤0.01%	835
2021 Q3	$435K	Hold	9,350	–	–	﹤0.01%	666
2021 Q2	$711K	Buy	+9,350	New	+$613K	0.01%	624

Other funds holding CALC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sculptor Capital's CALC Position: Q1 2022 in Review

Sculptor Capital sold out of CalciMedica (CALC) in Q1 2022, closing a stake of 9,350 shares — an estimated $240K sold.

Sculptor Capital first reported a position in CALC in Q2 2021 and held it in 3 quarters. The position peaked at $711K in Q2 2021. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2022.

Sculptor Capital reported no remaining CalciMedica position as of Q1 2022 after selling out during the quarter.
Sculptor Capital sold 9,350 CalciMedica shares in Q1 2022, an estimated $240K.
Sculptor Capital first reported a position in CalciMedica in Q2 2021 and held it in 3 quarters.
Sculptor Capital's CalciMedica position peaked at $711K in Q2 2021.
27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2022.

Based on Sculptor Capital's 13F filing for Q1 2022, filed 13 May 2022.